Should I buy Xencor Inc (XNCR) stock or is it too late?

Xencor Inc · Health Care · price $29
Logo Xencor IncSee the full Xencor Inc (XNCR) profile
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

Firm-by-firm track record on Xencor Inc

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Wedbush43 %+17.1 %7$30 +4%
RBC Capital33 %+8.7 %9$20 -31%
Canaccord Genuity40 %+5.9 %5$42 +45%
BMO Capital20 %-35.0 %5$34 +18%
In short — Should you invest in Xencor Inc? Is it too late, still worth it? Analysts are overwhelmingly positive (80% buy, median target $27, i.e. -7%), and the most reliable on XNCR targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • 80% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
  • The most reliable firm on XNCR, Wedbush (43% hit rate, 7 scored calls), targets $30 (call made on August 6, 2026, maturing on August 6, 2027) (+4%) in its most recent call, and $26 (call made on September 2, 2025, maturing on September 2, 2026) (-10%) in the one coming due soonest.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 5 ratings, 1 is neutral.
  • Limited upside: the median target is only -7% from the current price.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • No dividend: your return depends only on price appreciation.

The analyst consensus on XNCR

Median target $27 (-7%) · 5 ratings · Buy consensus

Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Xencor Inc now?

We won't decide for you. The facts: 80% of analysts rate it a buy, median target $27 (-7%), and Wedbush (most reliable on XNCR, 43%) targets $30. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Xencor Inc?

The stated upside is small: the median target ($27) sits just -7% from the price ($29) (most reliable on XNCR: Wedbush, 43%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Xencor Inc still worth investing in?

It depends on the gap between the price ($29) and its estimated value: analysts target $27 on median (-7%), with 80% buys (most reliable on XNCR: Wedbush, 43%). Cross-check with their real reliability on XNCR and the cautions above. Information, not advice.

What's the main risk in buying XNCR?

The consensus is not unanimous: of 5 ratings, 1 is neutral.

→ Go deeper: the full Xencor Inc profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)